Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

Investors are expected to be cautious with MEDPLUS, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 2.90300
forwardPE 39.13855
debtToEquity 64.68900
earningsGrowth 0.43000
revenueGrowth 0.06500
grossMargins 0.25567
operatingMargins 0.04781
trailingEps 16.28000
forwardEps 19.81167

MEDPLUS's current ratio is 2.903, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting MEDPLUS has no trouble covering its short-term financial obligations.
MEDPLUS's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights MEDPLUS's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

The current price of MEDPLUS, in relation to its projections, presents a neutral outlook. There are no discernible risks or opportunities at this stage, indicating that investors may need to await further developments to make informed decisions regarding their positions in the stock.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


Analysts have shown a buy bias for MEDPLUS, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to MEDPLUS, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.